Allison Luo, M.D.
Allison has served as our Chief Medical Officer since November 2017. Prior to joining Escalier, Allison was Vice President of Clinical Development at Ophthotech where she was responsible for the completion of two Phase 3 studies and the submittal of a New Drug Application with the Food and Drug Administration. Prior to Ophthotech, Allison was Executive Director with Bristol-Myers Squibb where she was responsible for leading their Inflammatory Bowel Disease strategy and led several Phase 2 and Phase 3 clinical development programs. Allison received her Doctor of Medicine and Bachelor of Science in Biochemistry from Northwestern University.